U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) insider Eric Joseph Williams sold 2,000 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the transaction, the insider now directly owns 14,814 shares in the company, valued at $1,419,773.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
U.S. Physical Therapy Stock Down 2.6 %
Shares of U.S. Physical Therapy stock traded down $2.44 during trading hours on Tuesday, hitting $92.17. The company had a trading volume of 111,576 shares, compared to its average volume of 91,789. The company’s 50-day moving average is $83.80 and its two-hundred day moving average is $91.31. The company has a market cap of $1.39 billion, a P/E ratio of 100.57, a price-to-earnings-growth ratio of 4.40 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.76 earnings per share. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Announces Dividend
Wall Street Analyst Weigh In
A number of equities analysts have commented on USPH shares. Bank of America reissued a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.
Get Our Latest Analysis on USPH
Hedge Funds Weigh In On U.S. Physical Therapy
A number of hedge funds have recently made changes to their positions in USPH. Silvercrest Asset Management Group LLC acquired a new stake in U.S. Physical Therapy during the 1st quarter valued at approximately $8,158,000. Renaissance Technologies LLC lifted its position in U.S. Physical Therapy by 763.7% in the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after buying an additional 61,474 shares in the last quarter. Penn Davis Mcfarland Inc. bought a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at $2,552,000. Dimensional Fund Advisors LP lifted its stake in shares of U.S. Physical Therapy by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after buying an additional 10,462 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after purchasing an additional 10,175 shares during the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- EV Stocks and How to Profit from Them
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 3 Stocks to Consider Buying in October
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Why Invest in 5G? How to Invest in 5G Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.